Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Nanoscale ; 10(41): 19628-19637, 2018 Nov 07.
Artigo em Inglês | MEDLINE | ID: mdl-30325388

RESUMO

The electromigration behaviour of raw and acid purified single walled carbon nanotubes (SWCNTs) in dilute aqueous systems (0.0034 mg mL-1), in the absence of surfactant, with the addition of either 0.85 M acetic acid or 0.1 M CuSO4, was evaluated using a 2-inch copper cathode and either a 2-inch copper or 0.5-inch platinum anode. The results showed that the electromigration of raw SWCNTs (with a high catalyst residue) in the presence of CuSO4 resulted in the formation of a Cu-SWCNT composite material at the cathode. In contrast, acid purified SWCNTs were observed to diffuse to a copper anode, creating fibrillated agglomerates with "rice-grain"-like morphologies. Upon acidification with acetic acid (or addition of CuSO4) the direction of electromigration reversed towards the cathode as a result of coordination of Cu2+ to the functional groups on the SWCNT overcoming the inherent negative charge of the acid purified SWCNTs. The result was the co-deposition of SWCNTs and Cu metal on the cathode. Addition of 0.005 M EDTA sequesters some of the Cu2+ and resulted in the separation of metal decorated SWCNTs to the cathode and un-decorated SWCNTs to the anode. The resulting SWCNT and Cu/SWCNT deposits were characterized by Raman spectroscopy, XPS, SEM, EDS, and TEM.

2.
BJOG ; 116(13): 1749-54, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19781045

RESUMO

OBJECTIVE: To characterise the haemodynamic, renal-electrolyte and hormonal parameters in normal near-term pregnancy. DESIGN: Observational prospective case-series study. SETTING AND POPULATION: Eleven women with normal pregnancies at 35-39 weeks gestation. METHODS: Following baseline laboratory assessments and placement of a right-atrial catheter, serial measurements were obtained for 2 hours in the supine position (SP) followed by a change to the (LLP) and subsequent observations for 2 hours. MAIN OUTCOME MEASURES: Blood pressure (BP), central venous pressure (CVP), atrial natriuretic peptide (ANP), plasma renin activity (PRA), plasma aldosterone (ALDO), diuresis, creatinine clearance, sodium and potassium excretion. RESULTS: In the SP, the subjects' BP remained stable while their CVP decreased. In the LLP, the subjects' systolic and diastolic BP consistently decreased by about 15 mmHg and their CVP increased within the first 60 minutes. ANP levels doubled in the subjects while they rested in the LLP, whereas the subjects' PRA and ALDO levels decreased by half compared with when they rested in the SP. In the LLP, the subjects' creatinine clearance significantly increased by 12% and their sodium excretion and diuresis increased by 38% and 59% respectively. CONCLUSION: Rest in the LLP induces systemic and intra-renal haemodynamic and hormonal changes that may play a central physiological role in the renal excretory response to restore excessive sodium/water retention in late pregnancy.


Assuntos
Pressão Sanguínea/fisiologia , Rim/metabolismo , Gravidez/fisiologia , Adaptação Fisiológica , Adolescente , Adulto , Aldosterona/sangue , Fator Natriurético Atrial/sangue , Creatinina/urina , Diurese/fisiologia , Feminino , Humanos , Postura/fisiologia , Potássio/urina , Gravidez/sangue , Gravidez/urina , Terceiro Trimestre da Gravidez/sangue , Terceiro Trimestre da Gravidez/fisiologia , Terceiro Trimestre da Gravidez/urina , Renina/sangue , Sódio/urina , Decúbito Dorsal/fisiologia , Adulto Jovem
3.
Nanotechnology ; 20(2): 025612, 2009 Jan 14.
Artigo em Inglês | MEDLINE | ID: mdl-19417281

RESUMO

Carbon nanotubes are a new class of nanomaterials that have immense potential in the field of biomedicine. Their ability to carry large quantities of therapeutic molecules makes them prime candidates for providing targeted delivery of therapeutics for use in various diseases. However, their utility is limited due to the problems faced during their delivery to target sites. This article for the first time describes the design of a novel microcapsule carbon nanotube targeted delivery device. This device has potential in the targeted delivery of carbon nanotubes in suitable membranes along with their cargo, safely and effectively to the target loci.


Assuntos
Cápsulas/uso terapêutico , Portadores de Fármacos/uso terapêutico , Nanotubos de Carbono , Animais , Humanos
4.
Toxicol Lett ; 169(1): 51-63, 2007 Feb 28.
Artigo em Inglês | MEDLINE | ID: mdl-17275220

RESUMO

Carbon nanotubes (CNT), despite their diverse application potential, have demonstrated adverse impacts in vitro and in vivo. Previous studies have focused on the combined in vitro cytotoxic impact of CNT aggregates and associated nanoparticulate impurities. However, the isolated effect of CNT aggregates and associated non-aggregated nanoparticulates have not been addressed in detail. In this work, the impact of single-walled nanotubes (SWNT) on rat aortic smooth muscle cells (SMC) was examined for SWNT (0.0-0.1 mg/ml) over a 3.5-day time-course. Cell culture medium was filtered to remove the aggregate material and both nanomaterial (un-filtered) and filtered SWNT media were used to examine cell growth. In general, the removal of SWNT aggregates from cell culture test medium by filtration increased the SMC number in comparison to unfiltered medium at pre-filtered SWNT dosages below 0.1 mg/ml. However, at 0.1 mg/ml, both filtered and unfiltered media exhibited a similar decrease in cell number relative to the control medium. The filtered medium was characterized and contained both suspended nanoparticles as well as a small quantity of SWNT, which may have contributed to the observed cell growth inhibition. As a comparison to the SWNT, activated carbon (0.1 mg/ml), a nanoporous, microparticulate carbon material, was found to be less inhibitory to SMC growth than the SWNT at the same dosage, implying an inverse proportionality between carbon nanomaterial size regimes and cell growth inhibition.


Assuntos
Músculo Liso Vascular/citologia , Nanotubos/toxicidade , Animais , Aorta Torácica/citologia , Agregação Celular/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Meios de Cultura , Relação Dose-Resposta a Droga , Corantes Fluorescentes , Processamento de Imagem Assistida por Computador , Indóis , Microscopia Eletrônica de Varredura , Tamanho da Partícula , Ratos , Reprodutibilidade dos Testes , Análise Espectral Raman
5.
Am J Nephrol ; 23(6): 422-8, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14573998

RESUMO

BACKGROUND/AIM: The aim of this study was to evaluate the effect of preventing hypertension on renal disease in a model of genetic hypertension and diabetes. METHODS: Four-week-old spontaneously hypertensive rats (SHR) with streptozotocin-induced diabetes were randomized for no treatment, or for treatment with captopril, losartan or triple therapy (hydrochlorothiazide, reserpine and hydralazine) for 16 weeks. RESULTS: Increase in systolic blood pressure was equally prevented by captopril (128 +/- 3 mm Hg), losartan (128 +/- 2) and triple therapy (129 +/- 2, p < 0.0001). Albuminuria was similarly reduced by captopril (499 (404-659)), losartan (622 (470-976)) and triple therapy (479 (362-600) microg/24 h (p < 0.0001)). Renal fibronectin expression increased in diabetic SHR (125 +/- 13 densitometric unit) as compared to the controls (51 +/- 9, p < 0.0001), and decreased (p < 0.0001 vs. diabetic SHR) with captopril (32 +/- 8), losartan (27 +/- 4) and triple therapy (35 +/- 6). CONCLUSION: The prevention of hypertension in diabetic SHR by captopril, losartan or triple therapy was equally efficacious in impeding increase of albuminuria and the expression of renal fibronectin. Under these conditions, tight blood pressure control was the main determinant in attenuating nephropathy.


Assuntos
Albuminúria/metabolismo , Diabetes Mellitus Experimental/metabolismo , Fibronectinas/metabolismo , Hipertensão Renovascular/prevenção & controle , Rim/metabolismo , Bloqueadores do Receptor Tipo 1 de Angiotensina II , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Animais , Anti-Hipertensivos/uso terapêutico , Pressão Sanguínea/efeitos dos fármacos , Western Blotting , Hipertensão Renovascular/metabolismo , Testes de Função Renal , Masculino , Ratos , Ratos Endogâmicos SHR
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA